Objective: The Merseburg triad (hyperthyroidism, goiter, and orbitopathy) characterizes classical description of Graves’ disease (GD). Aim of this observational, longitudinal study was to evaluate the current clinical features of newly diagnosed GD in Italy. Materials and methods: In two Northern Italy centers (Varese and Pavia), 283 consecutive patients (211 women, 72 men; mean age 47.4 years) with newly diagnosed GD were recruited in the years 2010–2014. Diagnosis was based on established criteria, and thyroid volume was assessed by ultrasonography. A clinical severity score (CSS) to assess the overall disease severity was developed by grading each component of the Merseburg triad. Results: At diagnosis, 45 % of patients had no goiter, and 30 % had a small goiter. The proportion of goitrous patients was much lower than in two Italian studies performed 20–30 years ago. Hyperthyroidism was subclinical in 16 % and mild in 29 % of patients, and Graves’ orbitopathy was present in 20 %, usually mild, and active in only 2.5 % of patients. Using the CSS, less than half (44 %) of the patients had severe GD, while 22 % had mild and 34 % moderate disease. CSS was associated with a significantly higher risk of poorly controlled hyperthyroidism at 6 months. Conclusions: In Italy, a relevant proportion of Graves’ patients at diagnosis have mild to moderate GD; about half of them have no goiter, slightly less than one-fifth have subclinical hyperthyroidism, and only 20 % have GO. Thus, the clinical phenotype of GD is milder than in the past, possibly due to both earlier diagnosis and treatment, and improved iodine nutrition.

The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study

BARTALENA, LUIGI;MASIELLO, ELVIRA ROBERTA;VERONESI, GIOVANNI;SPREAFICO, EMANUELE;GALLO, DANIELA;PREMOLI, PAOLA;PIANTANIDA, ELIANA ANGELA ROSA;TANDA, MARIA LAURA PIERA;FERRARIO, MARCO MARIO ANGELO;VITTI, PIERPAOLO;
2016-01-01

Abstract

Objective: The Merseburg triad (hyperthyroidism, goiter, and orbitopathy) characterizes classical description of Graves’ disease (GD). Aim of this observational, longitudinal study was to evaluate the current clinical features of newly diagnosed GD in Italy. Materials and methods: In two Northern Italy centers (Varese and Pavia), 283 consecutive patients (211 women, 72 men; mean age 47.4 years) with newly diagnosed GD were recruited in the years 2010–2014. Diagnosis was based on established criteria, and thyroid volume was assessed by ultrasonography. A clinical severity score (CSS) to assess the overall disease severity was developed by grading each component of the Merseburg triad. Results: At diagnosis, 45 % of patients had no goiter, and 30 % had a small goiter. The proportion of goitrous patients was much lower than in two Italian studies performed 20–30 years ago. Hyperthyroidism was subclinical in 16 % and mild in 29 % of patients, and Graves’ orbitopathy was present in 20 %, usually mild, and active in only 2.5 % of patients. Using the CSS, less than half (44 %) of the patients had severe GD, while 22 % had mild and 34 % moderate disease. CSS was associated with a significantly higher risk of poorly controlled hyperthyroidism at 6 months. Conclusions: In Italy, a relevant proportion of Graves’ patients at diagnosis have mild to moderate GD; about half of them have no goiter, slightly less than one-fifth have subclinical hyperthyroidism, and only 20 % have GO. Thus, the clinical phenotype of GD is milder than in the past, possibly due to both earlier diagnosis and treatment, and improved iodine nutrition.
2016
http://link.springer.com/journal/40618
Antithyroid drugs; Goiter; Graves’ disease; Graves’ orbitopathy; Hyperthyroidism; Thyrotropin receptor antibody; Endocrinology, Diabetes and Metabolism; Endocrinology
Bartalena, Luigi; Masiello, ELVIRA ROBERTA; Magri, F.; Veronesi, Giovanni; Bianconi, E.; Zerbini, F.; Gaiti, M.; Spreafico, Emanuele; Gallo, Daniela; ...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2058151
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 44
social impact